Skip to content

AdenoPlus RPS-AD

by Quidel Corp.

AdenoPlus RPS-AD is a Class I device made by Quidel Corp., listed in FDA GUDID since 10 Nov 2018 (UDI-DI 30014613336686), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number30014613336686 UDI-DI Date10 Nov 2018ListedStatusListed GUDID: in commercial distribution

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
AdenoPlus
Generic name
Adenovirus antigen IVD, kit, rapid ICT, clinical
Model / Ref / Catalog
RPS-AD
Primary DI / UDI-DI
30014613336686
FDA product code
GOD
GMDN term
Adenovirus antigen IVD, kit, rapid ICT, clinical
Device class
Class I
Regulation number
866.3020
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code GOD (ANTIGENS, CF (INCLUDING CF CONTROL), ADENOVIRUS 1-33).

Other devices from Quidel Corp.

See all devices from Quidel Corp. →

Properties

  • Single use
  • Prescription use
  • Convenience kit
  • Lot / batch number
  • Expiration date
Other properties (10, all answered No)